Concepedia

Publication | Open Access

Preventative Effects of Rosiglitazone on Restenosis After Coronary Stent Implantation in Patients With Type 2 Diabetes

244

Citations

35

References

2004

Year

Abstract

We demonstrated that treatment with rosiglitazone significantly reduces in-stent restenosis in diabetic patients with CAD who underwent coronary stent implantation.

References

YearCitations

Page 1